Insights

This study on pediatric typhoid fever highlights diagnostic challenges and treatment responses. Some children with typhoid fever may not respond to standard antibiotics like chloramphenicol or amoxicillin, requiring alternative treatments.

Area of Science:

  • Pediatric infectious diseases
  • Microbiology
  • Clinical pharmacology

Context:

  • Typhoid fever presents diagnostic challenges in children, with initial misdiagnosis in 38% of cases.
  • Common symptoms include fever, abdominal pain, and diarrhea; examination findings can include abdominal tenderness, delirium, and liver enlargement.
  • Hematological findings such as anemia and lymphopenia are noted in a significant percentage of pediatric typhoid patients.

Purpose:

  • To describe clinical features, treatment outcomes, and diagnostic considerations of typhoid fever in 77 children.
  • To evaluate the efficacy of chloramphenicol, amoxicillin, and ampicillin in treating pediatric typhoid fever.
  • To identify challenges in diagnosing and managing typhoid fever, particularly in cases with antibiotic resistance.

Summary:

  • A cohort of 77 children (48 boys, 29 girls) aged 1 month to 12 years with typhoid fever was treated with chloramphenicol, amoxicillin, or ampicillin.
  • The average fever duration was 5.2 days, with one relapse and one fatality in a one-month-old infant.
  • Two patients with resistant Salmonella typhi strains successfully responded to co-trimoxazole, underscoring the need for vigilance regarding antibiotic resistance.

Impact:

  • Highlights the importance of considering typhoid fever in pediatric patients, especially in certain populations.
  • Suggests that milk feeds may exacerbate symptoms like diarrhea and abdominal distension during the acute phase, recommending soya products as an alternative.
  • Emphasizes that some typhoid fever cases may exhibit resistance to chloramphenicol and amoxicillin, necessitating alternative therapeutic strategies.

Related Concept Videos

Acute Pharyngitis01:30

Acute Pharyngitis

Introduction
Acute pharyngitis is the inflammation of the back of the throat (pharynx), commonly resulting in a sore throat. It is a frequently encountered condition that prompts individuals to seek medical advice.
Classification
Acute pharyngitis can be categorized based on its underlying cause:
Tonsillitis I: Introduction01:30

Tonsillitis I: Introduction

Tonsillitis is inflammation of the tonsils, which are two lymphoid tissue masses at the back of the throat. This condition can cause discomfort and irritation in the throat.
Etiology
Three primary contributing factors have been identified.
Tonsillitis II: Management01:26

Tonsillitis II: Management

This lesson will focus on the different treatment options for managing tonsillitis, which typically depend on the cause and severity.
Diphtheria01:28

Diphtheria

Diphtheria is an acute, toxin-mediated infectious disease that primarily affects the upper respiratory tract. It is caused by Corynebacterium diphtheriae, a Gram-positive, pleomorphic rod that lacks spore-forming capability and exhibits a characteristic club-shaped morphology under microscopic examination. While C. diphtheriae can asymptomatically colonize mucosal surfaces, clinical disease manifests only when the bacterial strain is lysogenized by a specific β-corynephage. This phage...
Bacterial Gastroenteritis01:18

Bacterial Gastroenteritis

Bacterial gastroenteritis, characterized by diarrhea, abdominal cramps, and vomiting, is often caused by ingestion of contaminated food or water and is frequently associated with pathogenic Escherichia coli strains. These microbes exploit two principal mechanisms to inflict disease.Shiga toxin–producing E. coli, also referred to as STEC—notably O157:H7—release Shiga toxins that target ribosomes, blocking protein synthesis. The B subunit of the toxin binds the host glycolipid receptor...
Amebiasis01:28

Amebiasis

Entamoeba histolytica, a protozoan parasite, is responsible for intestinal and extraintestinal amebiasis. Though a significant proportion of infections remain asymptomatic, approximately 50 million individuals annually are estimated to present with clinical disease, resulting in up to 100,000 deaths globally. The disease burden is disproportionately high in regions with lower socioeconomic status, such as parts of India, Africa, Mexico, and Latin America.Etiology and TransmissionThe infective...